Custom Search


Sunday 01 July 2001

Alternative mechanisms for long-acting beta(2)-adrenergic agonists in COPD.

By: Johnson M, Rennard S.

Chest 2001 Jul;120(1):258-70

beta(2)-Adrenergic agonists are commonly used as bronchodilators to treat patients with COPD. In addition to prolonged bronchodilation, long-acting beta(2)-agonists (LABAs) exert other effects that may be of clinical relevance. These include inhibition of airway smooth-muscle cell proliferation and inflammatory mediator release, as well as nonsmooth-muscle effects, such as stimulation of mucociliary transport, cytoprotection of the respiratory mucosa, and attenuation of neutrophil recruitment and activation. This review details the possible alternative mechanisms of action of the LABAs, salmeterol and formoterol, in COPD.

Use of this site is subject to the following terms of use